72 related articles for article (PubMed ID: 15536332)
1. Pathologic study and clinical significance of Hürthle cell papillary thyroid carcinoma.
Mai KT; Thomas J; Yazdi HM; Commons AS; Lamba M; Stinson AW
Appl Immunohistochem Mol Morphol; 2004 Dec; 12(4):329-37. PubMed ID: 15536332
[TBL] [Abstract][Full Text] [Related]
2. Large (>4 cm) Intrathyroidal Encapsulated Well-Differentiated Follicular Cell-Derived Carcinoma Without Vascular Invasion May Have Negligible Risk of Recurrence Even When Treated with Lobectomy Alone.
Ghossein R; Ganly I; Tuttle RM; Xu B
Thyroid; 2023 May; 33(5):586-592. PubMed ID: 36884299
[No Abstract] [Full Text] [Related]
3. Subclassification of non-solid-type papillary thyroid carcinoma identification of high-risk group in common type.
Bai Y; Kakudo K; Li Y; Liu Z; Ozaki T; Ito Y; Kihara M; Miyauchi A
Cancer Sci; 2008 Oct; 99(10):1908-15. PubMed ID: 19016749
[TBL] [Abstract][Full Text] [Related]
4. Accuracy of World Health Organisation-grade parameters (necrosis and mitotic activity) and foci of vascular invasion in predicting prognosis of papillary thyroid carcinoma. A case-control validation study.
Ragazzi M; Besutti G; Mancuso P; Rossi PG; Ciarrocchi A; Donati B; Manzotti G; Giordano D; Frasoldati A; Chiaruccci F; de de Biase D; Coluccelli S; Maloberti T; De Leo A; Piana S; Tallini G
Histopathology; 2024 Jul; 85(1):62-74. PubMed ID: 38477417
[TBL] [Abstract][Full Text] [Related]
5. Papillary thyroid carcinoma tall cell subtype (PTC-TC) and high-grade differentiated thyroid carcinoma tall cell phenotype (HGDTC-TC) have different clinical behaviour: a retrospective study of 1456 patients.
Ghossein R; Katabi N; Dogan S; Shaha AR; Tuttle RM; Fagin JA; Ganly I; Xu B
Histopathology; 2024 Jun; 84(7):1130-1138. PubMed ID: 38528726
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic and prognostic utility of TROP-2, SLP-2, and CXCL12 expression in papillary thyroid carcinoma.
Attia AS; Hussein S; Sameh H; Khalil A; Waley AB; Matar I; Sameh R
Cancer Biomark; 2024; 39(3):211-221. PubMed ID: 38073379
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors of papillary and follicular carcinomas in Japan based on data of kuma hospital.
Ito Y; Miyauchi A
J Thyroid Res; 2012; 2012():973497. PubMed ID: 21977332
[TBL] [Abstract][Full Text] [Related]
8. Aberrant Intrathyroid Tissue: a Report of Intrathyroid Lymph Node Metastasis and a Review of Literature.
Shawky MS; Meyer-Rochow W
Indian J Surg; 2017 Apr; 79(2):148-152. PubMed ID: 28442842
[TBL] [Abstract][Full Text] [Related]
9. Tumour size predicts risk of recurrence in tall cell subtype papillary thyroid carcinoma.
Leong D; Leslie C; Laurie B; Hou L; Keyser J; Yew MK; Ryan S; Nguyen H; Lisewski D
Am J Surg; 2024 Mar; ():. PubMed ID: 38580566
[TBL] [Abstract][Full Text] [Related]
10. Recurrence rate in regional lymph nodes in 737 patients with follicular or Hürthle cell neoplasms.
Vogrin A; Besic H; Besic N; Music MM
Radiol Oncol; 2016 Sep; 50(3):269-73. PubMed ID: 27679542
[TBL] [Abstract][Full Text] [Related]
11. Synchronous Hürthle cell and medullary thyroid carcinomas.
Yeap ZH; Arman S; Stenhouse G; Isa A
BMJ Case Rep; 2022 May; 15(5):. PubMed ID: 35641084
[TBL] [Abstract][Full Text] [Related]
12. Clavicular Metastasis as an Initial Presentation of Papillary Thyroid Cancer.
Fung R; Fasen M; Warda F; Natter P; Nedrud S; Fernandes R; Alkhasawneh A; Gandhi GY
Case Rep Endocrinol; 2021; 2021():6662071. PubMed ID: 34484842
[TBL] [Abstract][Full Text] [Related]
13. Focal Tall Cell Change in Papillary Thyroid Carcinoma: Lessons Learned from Practices Adopting Rigid Criteria (Height to Width Ratio of 3).
Rossi ED; Pantanowitz L
Endocr Pathol; 2024 Mar; 35(1):80-81. PubMed ID: 38324206
[No Abstract] [Full Text] [Related]
14. Tall cell carcinoma with reversed polarity of the breast.
Luo L; Deng H; Luo T
Asian J Surg; 2024 Jun; ():. PubMed ID: 38876881
[No Abstract] [Full Text] [Related]
15. Oxyphilic papillary thyroid carcinomas.
Beckner ME; Heffess CS; Oertel JE
Am J Clin Pathol; 1995 Mar; 103(3):280-7. PubMed ID: 7872249
[TBL] [Abstract][Full Text] [Related]
16. Follicular and Hürthle cell carcinoma: predicting outcome and directing therapy.
Sanders LE; Silverman M
Surgery; 1998 Dec; 124(6):967-74. PubMed ID: 9854570
[TBL] [Abstract][Full Text] [Related]
17. The oncocytic variant of papillary carcinoma of the thyroid: a clinicopathologic study of 15 cases.
Berho M; Suster S
Hum Pathol; 1997 Jan; 28(1):47-53. PubMed ID: 9013831
[TBL] [Abstract][Full Text] [Related]
18. Patients with Oncocytic Variant Papillary Thyroid Carcinoma Have a Similar Prognosis to Matched Classical Papillary Thyroid Carcinoma Controls.
Carr AA; Yen TWF; Ortiz DI; Hunt BC; Fareau G; Massey BL; Campbell BH; Doffek KL; Evans DB; Wang TS
Thyroid; 2018 Nov; 28(11):1462-1467. PubMed ID: 30215297
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
